Most ongoing diabetes trials do not include outcomes important to patients

An analysis of ongoing randomized clinical trials (RCTs) in diabetes finds that only about 20 percent have as primary outcomes results that patients consider important, such as illness, pain, effect on function and death, according to a study in the June 4 issue of JAMA.

Read the whole article on Physorg

More from Physorg